{{Rsnum
|rsid=6077251
|Chromosome=20
|position=7771719
|Orientation=plus
|GMAF=0.1442
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 84.1 | 15.9 | 0.0
| HCB | 76.5 | 21.3 | 2.2
| JPT | 75.7 | 19.8 | 4.5
| YRI | 66.2 | 28.3 | 5.5
| ASW | 68.4 | 26.3 | 5.3
| CHB | 76.5 | 21.3 | 2.2
| CHD | 73.4 | 25.7 | 0.9
| GIH | 47.0 | 46.0 | 7.0
| LWK | 63.0 | 32.4 | 4.6
| MEX | 65.5 | 27.6 | 6.9
| MKK | 59.1 | 37.7 | 3.2
| TSI | 71.3 | 26.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=3E-6
  |OR=2.07
  |ORtxt=[1.537-2.773]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}